BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 10331587)

  • 41. Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome.
    Eichler EE; Macpherson JN; Murray A; Jacobs PA; Chakravarti A; Nelson DL
    Hum Mol Genet; 1996 Mar; 5(3):319-30. PubMed ID: 8852655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat.
    Sofola OA; Jin P; Botas J; Nelson DL
    Hum Mol Genet; 2007 Oct; 16(19):2326-32. PubMed ID: 17635840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expansion to full mutation of a FMR1 intermediate allele over two generations.
    Terracciano A; Pomponi MG; Marino GM; Chiurazzi P; Rinaldi MM; Dobosz M; Neri G
    Eur J Hum Genet; 2004 Apr; 12(4):333-6. PubMed ID: 14735162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reverse mutations in the fragile X syndrome.
    Brown WT; Houck GE; Ding X; Zhong N; Nolin S; Glicksman A; Dobkin C; Jenkins EC
    Am J Med Genet; 1996 Aug; 64(2):287-92. PubMed ID: 8844067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fragile X syndrome with FMR1 and FMR2 deletion.
    Moore SJ; Strain L; Cole GF; Miedzybrodzka Z; Kelly KF; Dean JC
    J Med Genet; 1999 Jul; 36(7):565-6. PubMed ID: 10424820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intermediate alleles at the FRAXA and FRAXE loci in Parkinson's disease.
    Costa A; Gao L; Carrillo F; Cáceres-Redondo MT; Carballo M; Díaz-Martín J; Gómez-Garre P; Sobrino F; Lucas M; López-Barneo J; Mir P; Pintado E
    Parkinsonism Relat Disord; 2011 May; 17(4):281-4. PubMed ID: 21257332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice.
    Lavedan C; Grabczyk E; Usdin K; Nussbaum RL
    Genomics; 1998 Jun; 50(2):229-40. PubMed ID: 9653650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of the allelic polymorphism of the five X-linked (CA)n dinucleotide repeats in Russia].
    Drozd OV; Strel'nikov VV; Babenko OV; Zemliakova VV; Nemtsova MV; Zaletaev DV
    Genetika; 2003 Mar; 39(3):433-8. PubMed ID: 12722645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of FMR3 expression in a male with non-syndromic mental retardation and a microdeletion immediately distal to FRAXE CCG repeat.
    Santos-Rebouças CB; Abdalla CB; Fullston T; Campos M; Pimentel MM; Gécz J
    Neurosci Lett; 2006 Apr; 397(3):245-8. PubMed ID: 16469443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical and molecular screening for fragile X syndrome in 300 patients with non-specific mental retardation].
    Jara L; López M; Mellado C; Aspillaga M; Avendaño I; Blanco R
    Rev Med Chil; 1998 Aug; 126(8):911-8. PubMed ID: 9830742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males.
    Biancalana V; Taine L; Bouix JC; Finck S; Chauvin A; De Verneuil H; Knight SJ; Stoll C; Lacombe D; Mandel JL
    Am J Hum Genet; 1996 Oct; 59(4):847-54. PubMed ID: 8808600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE.
    Parrish JE; Oostra BA; Verkerk AJ; Richards CS; Reynolds J; Spikes AS; Shaffer LG; Nelson DL
    Nat Genet; 1994 Nov; 8(3):229-35. PubMed ID: 7874164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequencies of "grey-zone" and premutation-size FMR1 CGG-repeat alleles in patients with developmental disability in Cyprus and Canada.
    Patsalis PC; Sismani C; Hettinger JA; Holden JJ; Lawson JS; Chalifoux M; Wing M; Walker M; Leggo J
    Am J Med Genet; 1999 May; 84(3):195-7. PubMed ID: 10331589
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetic diversity at the FMR1 locus in Mexican population.
    Rosales-Reynoso MA; Mendoza-Carrera F; Troyo-Sanromán R; Medina C; Barros-Núñez P
    Arch Med Res; 2005; 36(4):412-7. PubMed ID: 15950084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnosis of fragile X syndrome].
    Glover G; Bernabé MJ; Carbonell P
    Rev Neurol; 2001 Oct; 33 Suppl 1():S6-9. PubMed ID: 12447811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of unstable DNA sequence in FMR1 gene in Polish families with fragile X syndrome.
    Milewski M; Zygulska M; Bal J; Deelen WH; Obersztyn E; Bocian E; Halley DJ; Horst J; Mazurczak T
    Acta Biochim Pol; 1996; 43(2):383-8. PubMed ID: 8862184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular and genetic features of fragile X syndrome].
    Jara L; Avendaño I; Aspillaga M; Blanco R
    Rev Med Chil; 1996 Jul; 124(7):865-72. PubMed ID: 9138377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of fragile X mental retardation 1 CGG repeat and flanking haplotypes in a large Chinese population.
    Huang W; Xia Q; Luo S; He H; Zhu T; Du Q; Duan R
    Mol Genet Genomic Med; 2015 May; 3(3):172-81. PubMed ID: 26029703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mosaicism for full mutation and normal-sized allele of the FMR1 gene: a new case.
    Orrico A; Galli L; Dotti MT; Plewnia K; Censini S; Federico A
    Am J Med Genet; 1998 Jul; 78(4):341-4. PubMed ID: 9714436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fragile X founder chromosome effects: linkage disequilibrium or microsatellite heterogeneity?
    Zhong N; Ye L; Dobkin C; Brown WT
    Am J Med Genet; 1994 Jul; 51(4):405-11. PubMed ID: 7943008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.